|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_NoncurrentFinancialAssetSaleAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Evet (Yes)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
March 16, 2022
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_BoardDecisionDateForSale|
|
|
20/05/2022
|
|||||||
|
oda_WereMajorityOfIndependentBoardMembersApprovedTheBoardDecisionForSale|
|
|
Yes
|
|||||||
|
oda_TitleOfNoncurrentFinancialAssetSold|
|
|
Sentez Sağlık Hizmetleri A.Ş.
|
|||||||
|
oda_FieldOfActivityNoncurrentFinancialAssetSold|
|
|
Hospital Services
|
|||||||
|
oda_CapitalOfNoncurrentFinancialAssetSold|
|
|
TL 56,663,300.00
|
|||||||
|
oda_DateOnWhichRheTransactionWasWillBeCompleted|
|
|
May 20, 2022
|
|||||||
|
oda_SalesConditions|
|
|
Diğer (Other)
|
|||||||
|
oda_NominalValueOfSharesSold|
|
|
TL 31,733,000.00
|
|||||||
|
oda_SalesPricePerShare|
|
|
TL 100.00
|
|||||||
|
oda_TotalSalesValue|
|
|
TL 31,733,000.00
|
|||||||
|
oda_RatioOfSharesSoldToCapitalOfNoncurrentFinancialAsset|
|
|
56.00%
|
|||||||
|
oda_TotalRatioOfSharesOwnedInCapitalOfNoncurrentFinancialAssetAfterSalesTransaction|
|
|
0.00%
|
|||||||
|
oda_TotalVotingRightRatioOwnedInNoncurrentFinancialAssetAfterSalesTransaction|
|
|
0.00%
|
|||||||
|
oda_RatioOfNoncurrentFinancialAssetSoldToTotalAssetsInLatestDisclosedFinancialStatementsOfCompany|
|
|
0.51%
|
|||||||
|
oda_RatioOfTransactionValueToSalesInLatestAnnualFinancialStatementsOfCompany|
|
|
13.81%
|
|||||||
|
oda_EffectsOnCompanyOperations|
|
|
There is no significant effect. Under the subsidiary of Sentez Sağlık Hizmetleri A.Ş. (Sentez), 56.00% of which is owned and transferred by the MLP Care, three hospitals (İzmir, Gaziantep, and Batman) are operated.
|
|||||||
|
oda_ProfitLossArisedAfterTransaction|
|
|
According to our records kept in accordance with the Tax Legislation (Tax Procedure Law) and Uniform Chart of Accounts published by the Republic of Türkiye Ministry of Treasury and Finance (General Communique on the Application of the Accounting System), a TL 770 million profit was generated from the sale of the subsidiary.
|
|||||||
|
oda_HowWillSalesProfitBeUsedIfExists|
|
|
The cash proceeds from the transaction will be used for the opening of new hospitals and capacity expansion in existing facilities in line with our long-term growth strategies.
|
|||||||
|
oda_BoardDecisionDateForUseOfSalesProfitIfExists|
|
|
May 20, 2022
|
|||||||
|
oda_TitleNameSurnameOfCounterPartyBought|
|
|
MP Sağlık ve Ticaret A.Ş.
|
|||||||
|
oda_IsCounterPartyARelatedPartyAccordingToCMBRegulations|
|
|
Hayır (No)
|
|||||||
|
oda_RelationWithCounterPartyIfAny|http://www.xbrl.org/2003/role/verboseLabel
|
|
None.
|
|||||||
|
oda_AgreementSigningDateIfExists|
|
|
16/03/2022
|
|||||||
|
oda_ValueDeterminationMethodOfNoncurrentFinancialAsset|
|
|
Valuation Report
|
|||||||
|
oda_DidValuationReportBePrepared|
|
|
Düzenlendi (Prepared)
|
|||||||
|
oda_ReasonForNotPreparingValuationReportIfItWasNotPrepared|
|
|
None.
|
|||||||
|
oda_DateAndNumberOfValuationReport|
|
|
Report Dated on March 25, 2022
|
|||||||
|
oda_TitleOfValuationCompanyPreparedReport|
|
|
KPMG Yönetim Danışmanlığı A.Ş.
|
|||||||
|
oda_ValueDeterminedInValuationReportIfExists|
|
|
According to the sensitivity analysis, the value determined for the 100.00% of shares is between TL 976,000,000.00 and TL 1,031,000,000.00. Related sale transaction is for the sale of 56.00% of Sentez shares.
|
|||||||
|
oda_ReasonsIfTransactionWasntWillNotBePerformedInAccordanceWithValuationReport|
|
|
None.
|
|||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
The share transfer process, which started on March 16, 2022 with the share transfer agreement regarding two of the subsidiaries (Sentez and MS Sağlık) between MLP Sağlık Hizmetleri A.Ş. (MLP Care) and MP Sağlık ve Ticaret A.Ş. (MP Sağlık), was completed on May 20, 2022. The Non-Current Financial Asset Sale and Non-Current Financial Asset Acquisition transactions detailed above are considered below the limits set in article 6 Significance criterion of the Capital Markets Board's II-23.3 Common Principles Regarding Material Transactions and the Right to Leave (CMB Communique II-23.3). This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail. |
||||||||